The temperature-sensitive liposome is now in Phase I human clinical trials. This review will provide an update, recapping earlier work and presenting new data that show unexpected mechanistic features that make this triggered-release system an emerging new paradigm for local drug delivery.
No takes yet. Share an insight, caveat, or question.
Ponce et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: